Analysts Set Ascendis Pharma A/S (NASDAQ:ASND) Target Price at $204.67
Shares of Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) have earned an average recommendation of “Moderate Buy” from the fifteen ratings firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 12-month […]
Shares of Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) have earned an average recommendation of “Moderate Buy” from the fifteen ratings firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 12-month […]
